| Publication Type: | Article |
| Journal Name: | Health Affairs |
| Full Citation: | Amin T, Kesselheim, AS. Secondary patenting could extend US market exclusivity of HIV drugs Norvir and Kaletra through 2028. Health Affairs, 2012;31:2286-2294. |
| External Link: | Link |
| Project: | Sources of Transformative Innovation in Medication Development |
| People: | Aaron Kesselheim |